AI / data analytics / healthtech / informatics

#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Watch now: Real-time chemistry coordination for modern drug discovery

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

Neural networks
#AI / data analytics / healthtech / informatics #Cancer Research Horizons #Drug discovery #Francis Crick Institute #Medicines Discovery Catapult (MDC)

National programme to support data-driven health start-ups 

Applications have opened for a national accelerator programme supporting data-driven health innovation.  KQ Labs, led by the Francis Crick Institute and Medicines Discovery Catapult (MDC), is an annual five-month programme for early-stage companies building science-backed, scalable solutions in AI-driven drug discovery, digital health, and precision medicine. … Read More

#News

Chemistry
#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Watch now: Coordinate compound synthesis in real time

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

Claude AI app
#AI / data analytics / healthtech / informatics #Anthropic #Artificial intelligence (AI) #Drug discovery

Anthropic launches into drug discovery with Claude Science

Anthropic has launched Claude Science, an app that it says integrates the tools and packages that researchers most commonly use, produces auditable artifacts, and provides flexible access to computing resources.  At the launch event, the company also announced that it will be using the product to pursue some of its… Read More

#Business & Investment #Editor's Choice #News #Trending News

Informatics
#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Webinar: Real-time chemistry coordination for modern drug discovery

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

#News

Informatics
#AI / data analytics / healthtech / informatics #Drug discovery #Webinar

Beyond spreadsheets: Real-time chemistry coordination for modern drug discovery

In drug discovery, valuable scientific insights are often scattered across spreadsheets, slide decks and email threads. Chemistry teams spend hours preparing for update meetings, chasing CRO progress and digging into the data to find out what has been done before. When hypotheses and learnings only live in slides or individual… Read More

Webinar date:
Supported by Elixir
#Webinars

#AI / data analytics / healthtech / informatics #Clinical trials #Drug development #Drug discovery

AI in clinical data management: What actually works 

By Sandy Tammisetty, VP of the Veeva Services Practice Group at Conexus Solutions.  Artificial intelligence (AI) is no longer a future concept in clinical trials. It is already influencing how clinical data is reviewed, monitored, and analysed, particularly as trials become more complex and data volumes continue to grow. From anomaly detection to advanced… Read More

#Exclusive Content

Laboratory automation
#AI / data analytics / healthtech / informatics #Automation #Automation / robotics #Lab technology

Whitepaper: How workflow scheduling software can answer the demands of automated labs

Read this Whitepaper to understand how Thermo Fisher’s Momentum Workflow Scheduling Software is helping automated labs perform more effectively. You will learn: The current challenges labs face operating automated workflows How workflow scheduling integrates instruments for operational efficiency Why data harmonisation matters Download your copy now. Read More

#News

#AI / data analytics / healthtech / informatics #EMA #FDA #Regulatory

Why pharma must refocus its data efforts if it really wants to exploit AI

Now that this industry is seriously looking to advanced automation to reinvent the work it does, the data transformation imperative has soared back up the strategic agenda, says Ian Crone, ArisGlobal’s VP Europe & APAC Regulatory Solutions. Here, he reports on an impassioned panel debate that took place as part of the Life Science AI Exchange Podcast last year. The panel included subject… Read More

#Exclusive Content #Opinion

business deal
#AI / data analytics / healthtech / informatics #Drug discovery #Mergers and acquisitions #Multi-omics

UCB to acquire IMIDomics’ Patient Insight Business  

Global pharmaceutical company UCB has acquired the Patient Insights Business of IMIDomics, giving it access to a large, multi-omics dataset for immunology studies.  IMIDomics’ Patient Insight Business includes over 18 years of clinical and molecular data generation. It integrates epidemiological information, clinical histories, imaging data, multi-omic profiles, and longitudinal patient samples.  … Read More

#News

AI concept image
#AI #AI / data analytics / healthtech / informatics #Antibodies #Drug discovery

The structural data bottleneck in AI antibody discovery

Dan Benjamin, Co-Founder & Chief Technology Officer of Immuto Scientific, examines why limited antibody–antigen co-structure datasets may be constraining AI model performance—and how high-throughput structural generation could reshape the field. Artificial intelligence now plays a central role in antibody discovery. Machine learning models assist in sequence design, paratope prediction, affinity… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #Genomics #Multi-omics

Tipping the genomic scales: Preparing for the integrated multiomics era

This paid-for advertorial by Sampled appeared in DDW Volume 27 – Issue 2, Spring 2026   How sequencing innovation and integrated workflows are enabling reproducible multiomic studies. Genomics has always played a central role in advancing research and drug discovery, but utilising genomic data to inform decisions in the clinic has not always been possible. Progress in this area has been limited… Read More

#Exclusive Content

#AI / data analytics / healthtech / informatics #ALS #Alzheimer's #Axol Bioscience #Biologics #Centessa Pharmaceuticals #Corcept Therapeutics #Denali Therapeutics #Eli Lilly #FDA #Hunter Syndrome #LifeArc #Mergers and acquisitions #MND #Ovarian cancer #Stanford University

DDW Highlights: 7 April 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, there were crucial developments in neuroscience drug discovery. Elsewhere, a new treatment for… Read More

#Podcasts

#AI / data analytics / healthtech / informatics #Biotech #Drug development #Investment #Market reporting

Treehill Partners: Reflections on JPM and trends for 2026  

DDW Editor Reece Armstrong speaks to Ali Pashazadeh, CEO of capital market company Treehill Partners, about how his experience of this year’s JPM reflects how the industry will move forward in 2026.   The beginning of a new year in drug discovery and development is always marked with the arrival of the JP Morgan Healthcare Conference… Read More

#Business & Investment #Exclusive Content

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

2026: What will change in preclinical and clinical development?

How will preclinical discovery and clinical trials change in the coming year? And what role will regulators play? Diana Turner asks industry leaders for their predictions for 2026. A number of innovations are predicted to influence R&D in 2026, in both preclinical and clinical trials, including structural biology, real-world evidence… Read More

#Exclusive Content #Trends & Analysis

2026 ideas
#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Machine learning

Drug discovery and development in 2026

Which drug modalities will dominate the market, and which global regions will be most influential? Diana Turner asks industry leaders for their predictions for 2026. The opportunities and challenges facing biotech and biopharma in 2026 are concisely summarised by Dr Kevin Land, Executive Medical Director Biotherapies and Vice President Clinical… Read More

#Exclusive Content #Trends & Analysis